$7.84
0.040.51%
At close: -
$7.84
0.000.00%
After Hours: Dec 20, 4:04 PM EDT
Cogent Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Cogent Biosciences using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-12 | $-0.64 | $-0.57 | -12.3 % |
Jun 2024 | 2024-08-06 | $-0.59 | $-0.56 | -5.36 % |
Mar 2024 | 2024-05-07 | $-0.62 | $-0.51 | -21.6 % |
Dec 2023 | 2024-02-26 | $-0.63 | $-0.55 | -14.5 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Cogent Biosciences (COGT) is scheduled to report earnings on February 24, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
The Actual EPS was $-0.64, which missed the estimate of $-0.57.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.